CVI Holdings’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,197
Closed -$585K 64
2018
Q4
$585K Buy
+12,197
New +$669K 1.3% 12

Other funds holding VBIV

CVI Holdings's VBIV Position: Q1 2019 in Review

CVI Holdings sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2019, closing a stake of 12,197 shares — an estimated $585K sold.

CVI Holdings first reported a position in VBIV in Q4 2018 and held it in 1 quarter. The position peaked at $585K in Q4 2018. 43 funds tracked by Wall St. Rank hold VBIV as of Q1 2019.

  • CVI Holdings reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2019 after selling out during the quarter.
  • CVI Holdings sold 12,197 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2019, an estimated $585K.
  • CVI Holdings first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2018 and held it in 1 quarter.
  • CVI Holdings's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $585K in Q4 2018.
  • 43 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2019.

Based on CVI Holdings's 13F filing for Q1 2019, filed 15 May 2019.